
The human change challenge: How Sanofi gets workforce buy-in for AI
As transformation accelerates, HR leaders should keep their people up to speed, explains Sanofiās Raj Verma.
Artificial Intelligence is revolutionizing business operations, driving unprecedented productivity gains, and potentially adding trillions to the global economy. IMD faculty, industry practitioners, and global thought leaders guide you through the strategic integration of AI into your organization, showing you how to combine existing capabilities with cutting-edge technology to unlock transformative value.
Discover how to build new organizational capabilities that harness AI’s power while reimagining your strategy through a digital-first lens. Learn to navigate the complexities of AI implementation, from identifying high-impact use cases to developing the responsible leadership mindset needed to drive successful digital transformation.

The AI Maturity Index evaluates an organizationās AI maturity across five key dimensions to determine how effectively the organization leverages AI technologies to transform its business operations and strategies.

As transformation accelerates, HR leaders should keep their people up to speed, explains Sanofiās Raj Verma.

AI investment is soaring but returns remain elusive. The problem is not the technology ā it is the absence of three critical leadership capabilities.

Artificial intelligence (AI) has become a core driver of innovation in the pharmaceutical industry, with its most established applications in R&D. Leading companies use AI across the development pipeline to enhance speed and precision. While its full impact is still emerging, these advances point to a broader opportunity to extend AI beyond R&D.

AI efficiency gains dominate business cases, but capability losses are systematically underestimated and often ignored. Vsevolod Shabad explains how to mitigate this critical risk.

While humor boosts likability and success with human recruiters, it risks backfiring with AI interviewers. Candidates must adopt a ābilingualā strategy to avoid being penalized, say Jamie Gloor, Cecily Cooper, T Bradford Bitterly, and Clemens Stachl

Michael Wade and Massimo Marcolivio offer eight ways for healthcare companies to deliver better outcomes for patients and providers.

As generative AI erases the visible difference between real and fabricated content, authenticity becomes a strategic imperative. Prashant Saxena explains why perceived authenticity depends on three factors operating together and shows how to navigate this new reality.

AI is profoundly transforming the business landscape, presenting both significant opportunities and new challenges to boards. Here are five ways to use the technology as a powerful boardroom ally.

Cyril Bouquet shows how to improve your return on AI investment by matching your strategy to your organizational reality and selecting among four diļ¬erent AI innovation approaches.

JosƩ Parra Moyano joins Mike Wade & Amit Joshi to explore how Gen AI empowers business leaders, democratizes analytics, and drives innovation.

Explore how generative AI is reshaping supply chains with IMDās Carlos Cordon on Mike and Amit Talk Tech, driving smarter and adaptive solutions.

Discover how AI will revolutionize healthcare! Mike and Amit are joined by Achim Plueckebaum on the latest edition of the IMD Podcast Network to explore the future of medicine.

AI is revolutionizing the world of business, at pace. How do executives guarantee this mass adoption benefits both their organizations and society? In Issue XIII of I by IMD, we explore how to lead effectively - and responsibly - in the age of AI.
Ā
This report sets out the ļ¬ndings of a proprietary survey on exposure, adoption, and attitudes towards usage and regulation of Artiļ¬cial Intelligence (AI) and generative AI (GenAI) in Switzerland in 2024. It also shares the expert insights of our co-authors and leaders from business, academia, and the public sector captured at two dedicated workshops on disruptive technologies, including GenAI, in October and November 2023.

Explore first person business intelligence from top minds curated for a global executive audience